The patented know error® system provides a DNA confirmation for biopsy patients. This unique system uses bar coding, forensic principles and DNA matching to confirm that the biopsy samples being evaluated belong exclusively to the patient being diagnosed. Complementing conventional histopathology with DNA Specimen Provenance Assay (DSPA) significantly improves the biopsy-pathology-diagnosis test cycle, giving physicians and patients more complete diagnostic data on which to base treatment and therapy decisions. A pathology report alone vs. a pathology report with DSPA concurrence is the difference between believing the patient has cancer, and knowing the patient has cancer.
Visit our product website knowerror.com to learn more.